Schrödinger Raises 2026 ACV Guidance to $222 Million-$232 Million

By Public Technologies
  • Schrödinger raised its 2026 annual contract value guidance to $222 million–$232 million, representing 12%–17% growth.
  • Drug discovery revenue is now forecast at $75 million–$85 million, up from $65 million–$75 million.
  • Operating expenses are expected to be lower than in 2025.
  • Third-quarter 2026 revenue rose 19% to $64.5 million, supporting the improved outlook.
  • The company targets positive adjusted EBITDA by the end of 2028, with annual contract value growth of 10%–15% annually.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schrodinger Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.